why choose us

First received: July 08, 2022

Clinical Trial: Adipose-derived MSC to Treat Rejection in Kidney Transplant Recipients

Study Status: Completed

Recruit Status: RECRUITING

Condition: Kidney Transplant

Study Type: INTERVENTIONAL


Official Title: Safety of Intraarterial Infusion of Adipose Tissue-derived Mesenchymal Stromal Cells to Treat Antibody-mediated and Cellular Rejection in Adult Kidney Transplant Recipients (AMSCAR)

Brief Summary: This research study is being done to learn if an experimental treatment of infusing allogeneic adipose-derived mesenchymal stromal cells (allo-A-MSC ) directly into the renal artery is safe and can help reduce inflammation in the transplanted kidney and treat rejection.

Read more